Carlo Montemagno

Carlo Montemagno Ingenuity Lab

Driven by the principles of excellence, honor and responsibility and an unwavering commitment to education as an engine of economic prosperity, Carlo Montemagno, PhD has become a world-renowned expert in nanotechnology and is responsible for creating groundbreaking innovations which solve complex challenges in the areas of informatics, agriculture, chemical refining, transportation, energy, and healthcare.

Driven by the principles of excellence, honor and responsibility and an unwavering commitment to education as an engine of economic prosperity, Carlo Montemagno, PhD has become a world-renowned expert in nanotechnology and is responsible for creating groundbreaking innovations which solve complex challenges in the areas of informatics, agriculture, chemical refining, transportation, energy, and healthcare.

He was Founding Dean of the College of Engineering and Applied Sciences at University of Cincinnati; received a Bachelor of Science degree in Agriculture and Bio Engineering from Cornell University; a Master’s Degree in Petroleum and Natural Gas Engineering from Penn State and a PhD in Civil Engineering and Geological Sciences from Notre Dame. He is now in Alberta as the Director of Ingenuity Lab, professor in the Department of Chemical and Materials Engineering at the University of Alberta, AITF Strategic Chair of Bionanotechnology, Program Lead of the Biomaterials Program at the National Institute for Nanotechnology and Canada Research Chair in Intelligent Nanosystems.

“Research and education are critical to success because the transfer of knowledge creates economic prosperity.” — C. Montemagno

Carlo Montemagno has been recognized with prestigious awards including the Feynman Prize (for creating single molecule biological motors with nano-scale silicon devices); the Earth Award Grand Prize (for cell-free artificial photosynthesis with over 95% efficiency); the CNBC Business Top 10 Green Innovator award (for Aquaporin Membrane water purification and desalination technology); and named a Bill & Melinda Gates Grand Challenge Winner (for a pH sensing active microcapsule oral vaccine delivery system which increased vaccine stability and demonstrated rapid uptake in the lower GI tract.)

NANOSCALE

  • 05 June 2017
  • Main Stage
  • 4:15 pm - 4:30 pm
MORE INFO